Professor of Medicine, Case Western Reserve University School of Medicine, University Hospitals, 11100 Euclid Avenue, Lakeside 3rd floor, Cleveland, OH 44106 USA.
J Invasive Cardiol. 2021 Mar;33(3):E173-E180. Epub 2021 Feb 11.
We sought to evaluate the impact of pulmonary embolism (PE) response teams (PERTs) on all consecutive patients with PE.
Multidisciplinary PERTs have been promoted for the management and treatment of (PE); however, the impact of PERTs on clinical outcomes has not been prospectively evaluated.
We prospectively studied 220 patients with computed tomography (CT)-confirmed PE between January, 2019 and August, 2019. Baseline characteristics, as well as medical, interventional, and operational care, were captured. The total population was divided into 2 groups, ie, those with PERT activation and those without PERT activation. PERT activation was left at the discretion of the primary team. Our primary outcome was 90-day composite endpoint (rate of readmission, major bleeds, and mortality). Using 2:1 propensity-matched and multivariable-adjusted Cox proportional hazard analyses, we examined the impact of PERT activation on primary outcome, treatment approach, and length of stay.
Of the total 220 patients, PERT was activated in 47 (21.4%). The PERT cohort, as compared with the non-PERT cohort, was more likely to present with dyspnea, syncope, lower systolic blood pressure, higher heart rate, higher respiratory rate, lower oxygen saturation, higher troponin levels, and higher right ventricular to left ventricular ratio. PERT activation was associated with increased use of advanced therapies (36.2% vs 1.2%; P<.001) and catheter-directed inventions (25.5% vs 0.6%; P<.001). In multivariable-adjusted analysis of propensity-matched cohorts, PERT activation was associated with lower 90-day outcomes (hazard ratio, 0.40; 95% confidence interval, 0.21-0.75; P<.01).
At our institution, PERT had a clinically significant impact on therapeutic strategies and 90-day outcomes in patients with PE.
我们旨在评估肺栓塞(PE)反应团队(PERT)对所有连续的 PE 患者的影响。
多学科 PERT 已被推广用于管理和治疗(PE);然而,PERT 对临床结局的影响尚未得到前瞻性评估。
我们前瞻性研究了 2019 年 1 月至 2019 年 8 月期间 220 例 CT 证实的 PE 患者。记录了基线特征以及医疗、介入和操作护理。总人群分为 2 组,即 PERT 激活组和未激活 PERT 组。PERT 的激活取决于初级团队的决定。我们的主要结局是 90 天复合终点(再入院率、大出血和死亡率)。使用 2:1 倾向匹配和多变量调整 Cox 比例风险分析,我们检查了 PERT 激活对主要结局、治疗方法和住院时间的影响。
在 220 例患者中,有 47 例(21.4%)激活了 PERT。与非 PERT 组相比,PERT 组更有可能出现呼吸困难、晕厥、收缩压低、心率高、呼吸急促、氧饱和度低、肌钙蛋白水平高和右心室与左心室比值高。PERT 激活与更高级治疗方法(36.2%对 1.2%;P<.001)和导管定向发明(25.5%对 0.6%;P<.001)的应用增加相关。在倾向匹配队列的多变量调整分析中,PERT 激活与 90 天较低的结局相关(风险比,0.40;95%置信区间,0.21-0.75;P<.01)。
在我们的机构中,PERT 对 PE 患者的治疗策略和 90 天结局产生了显著的临床影响。